GlobeNewswire 2017-08-03 IGC’s CEO and Key Scientific Advisor Quoted in “HIGH TIMES” Article on THC and Alzheimer’s Disease
GlobeNewswire 2017-08-01 IGC Builds Team Adding Industry Leader Dr. Chuanhai Cao, an expert on THC-Based Alzheimer’s Disease ...
GlobeNewswire 2017-07-14 IGC Announces Financial Results for Fiscal Year Ended March 31, 2017
GlobeNewswire 2017-06-12 IGC Acquires Exclusive Rights to THC-based treatment for Alzheimer’s Disease
GlobeNewswire 2017-05-16 IGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, C...
GlobeNewswire 2017-04-21 NYSE MKT Extends India Globalization Capital Compliance Plan Period
GlobeNewswire 2017-04-10 IGC Files International Patents for IGC-501 Compound Indicated for Neuropathic Pain
GlobeNewswire 2017-04-05 IGC Sells Malaysian Hotel Investment Interest
GlobeNewswire 2017-04-05 India Globalization Capital Receives Letter from NYSE MKT LLC
GlobeNewswire 2017-03-21 IGC Files Patent for Cannabis-based Combination Therapy for Treatment of Eating Disorders
GlobeNewswire 2017-02-22 IGC Announces Third Quarter Financial Results
GlobeNewswire 2017-02-17 India Globalization Capital Announces the Extension of Warrants’ Expiry Date and Inducement Grant to...
GlobeNewswire 2017-02-13 IGC Launches Phytocannabinoid Development Committee to Secure Preclinical Initiatives for IGC-501, I...
GlobeNewswire 2017-01-06 IGC Update on Iron Ore Subsidiary
GlobeNewswire 2016-12-13 IGC’s CEO to Participate as Panelist at NY CPA Society Marijuana Symposium
GlobeNewswire 2016-11-21 IGC Announces Financial Results for Quarter Ended September 30, 2016
GlobeNewswire 2016-11-21 IGC Appoints John Cherin as CFO, Treasurer and PAO